Office of Research & Development |
  |
Talk to the Veterans Crisis Line now
An official website of the United States government
Project Number: | I01RX002806-01A1 |
| Title: | A TrkB Activator for Treatment of Glaucoma |
| Principal Investigator: | Jeffrey H Boatright |
| Location: | Decatur, GA |
| Congressional District Code: | 4 |
| Research Service: | Rehabilitation R&D |
| Project Period: | October 2018 - September 2023 |
| FY 2021 Funding Amount: | $174,988 |
| Total Award Amount (all years): |
$1,100,000 |
| Abstract: |
View full abstract and other project information on NIH RePORTER Go To NIH RePORTER Excerpt: Glaucoma is a serious and growing health problem for our nation's Veterans. At least 285,000 Veterans (possibly over 700,000) have this chronic disease, the leading cause of irreversible blindness globally. Prevalence is greater among Veterans than in the general population and is increasing dramatically. Women Veterans and blast injury survivors are at higher risk for developing glaucoma as they age. Glaucoma is a serious problem for our nation's Veterans; we intend to do something about this.... |